ORIGINAL RESEARCH
Accepted on 26 Mar 2025
TP53 mutation and immunohistochemical p53 expression characteristics in diffuse large B-cell lymphoma
doi 10.3389/fonc.2025.1550207
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Overcoming Resistance of Immune Checkpoint Inhibitors
Overcoming Resistance of Immune Checkpoint Inhibitors
888
Total downloads
2,715
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
SYSTEMATIC REVIEW
Published on 31 Jan 2025
Prognostic and clinicopathological role of soluble programmed cell death ligand-1 in patients with diffuse large B-cell lymphoma: a meta-analysis
doi 10.3389/fonc.2025.1506799
- 438 views
REVIEW
Published on 26 Nov 2024
Traditional Chinese medicine and its components effectively reduce resistance mediated by immune checkpoint inhibitors
doi 10.3389/fimmu.2024.1429483
- 1,035 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.